A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load. (Q46698308)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Vicente Estrada

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Arranz Caso JA

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

López JC

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Santos I

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Castilla V

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sanz J

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sanz J

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Molina JP

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Fernández Guerrero M

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Górgolas M

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 September 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

353-359

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16156884%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Switch studies: a review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Determinants of virological response to antiretroviral therapy: implications for long-term strategies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Monitoring adherence to HIV therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00320.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46698308&oldid=1582856726"